Pharmacokinetics of ophthalmic corticosteroids. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics of ophthalmic corticosteroids.

Pharmacokinetics of ophthalmic corticosteroids.

http://www.wikidata.org/entity/Q35653063

about

Medical management of uveitis - current trends An inducible expression system to measure rhodopsin transport in transgenic Xenopus rod outer segments Modified titanium implant as a gateway to the human body: the implant mediated drug delivery system.The ocular distribution of (14)C-labeled bromfenac ophthalmic solution 0.07% in a rabbit model.A review of evidence guiding the use of corticosteroids in the treatment of intraocular inflammation.Efficacy and Safety of Intravitreal Dexamethasone Implants for Treatment of Refractory Diabetic Macular Edema Bromfenac ophthalmic solution for the treatment of postoperative ocular pain and inflammation: safety, efficacy, and patient adherence.Delivery of steroids into the eye for the treatment of macular edema.Long Term and Intensive Use of Ophthalmic Topical Corticosteroids and the Risk of Positive Doping Test in Athletes: A Case Report.Effectiveness of specific antibiotic/steroid combinations for therapy of experimental Pseudomonas aeruginosa keratitis.Reply to: Costa DC et al. The use of subconjunctival triamcinolone acetonide (SCTA) in the management of corneal endothelial graft rejection.Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.

P2860

Q27003399-BD672036-6EDB-4041-98AA-21ACE277994F Q27342685-AA1DE2CE-B74A-47A1-B226-077AEC992697 Q34032573-D174C223-D9E1-47EF-AD99-E218153AD3B3 Q34160692-3510BBEC-D14C-4FD6-9CC8-14378FFA74F8 Q35895945-4BFF318C-F519-460E-88E1-785680310EB4 Q36331293-D297D897-E25E-42F9-92B4-70CC5694B23D Q38230010-3C661722-81F2-4CBA-A171-96EDE688494B Q38815223-B18F6B1E-35BF-452D-B10F-9C4C4CF73993 Q41307124-E5F3360B-E092-417A-AE99-9AEB54EE0A11 Q44265624-BE87B1D7-99D3-452C-81F1-C4A94CD06FE9 Q46189073-1C4AAED6-F2C3-4459-A28C-45EB4C54EF5D Q53077324-34483609-5589-4058-A133-374C67DBB991

P2860

Pharmacokinetics of ophthalmic corticosteroids.

http://www.wikidata.org/entity/Q35653063

description

1992 nî lūn-bûn

@nan

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

1992年论文

@zh

1992年论文

@zh-cn

name

Pharmacokinetics of ophthalmic corticosteroids.

@ast

Pharmacokinetics of ophthalmic corticosteroids.

@en

type

label

Pharmacokinetics of ophthalmic corticosteroids.

@ast

Pharmacokinetics of ophthalmic corticosteroids.

@en

prefLabel

Pharmacokinetics of ophthalmic corticosteroids.

@ast

Pharmacokinetics of ophthalmic corticosteroids.

@en

P1433

Q35653063-8BA1F33F-DF80-4C59-A0AE-7C53D7D34BA4

P1476

Q35653063-2AE58F2C-9A03-4606-82CF-FEA6191A16AB

P2093

Q35653063-394B41BB-05B8-4BE1-A78A-3B0B21BAAD8C

P2860

Q35653063-1AB6E120-FD67-405E-B460-E079B16491BA

Q35653063-2DF829C7-9437-4679-BEAA-B22E20A178B9

Q35653063-38179EA5-7253-4C98-AA36-C8EB2E054C07

Q35653063-3F647743-4DBE-459E-B358-FF42DE929DF2

Q35653063-464B636E-A83F-4FC1-83D1-6C9CBAFB6AB6

Q35653063-4F0AF65F-C966-4FE7-862D-47D6D1E74321

Q35653063-524A9AA4-D68F-47CF-BA78-3694D08E5D10

Q35653063-5FA342B0-8E1F-4582-8F86-1F703D5E391C

Q35653063-66D0661D-262E-4B57-8986-59CEA751D775

Q35653063-8688FB51-C86F-4016-AD87-5FE912FAA6CA

P304

Q35653063-A8D8BA50-3797-4E32-B6A1-0309AF05E9FA

P31

Q35653063-2D87E758-A96A-498C-A11A-A2525F7FC7B8

P356

Q35653063-12C8D178-AB77-4640-A3D1-5A87A3B85E7B

P407

Q35653063-1C88A555-B540-4D37-9CE6-49E20D11DBD3

P433

Q35653063-257CBC6D-2A3E-4F69-A8AA-1B188F9C7905

P478

Q35653063-26C961E3-CFBE-49F1-A41A-B23E71307F6D

P577

Q35653063-A4C4F17F-1DEA-4963-96B1-72B2B202BE5B

P5875

Q35653063-D7F4E605-342D-4CDA-ACC2-C3E83AD06FC0

P698

Q35653063-6A0C1FEB-1AD5-4173-8CB7-4386494B1506

P932

Q35653063-F48C5211-D94B-4704-9F66-31A2D90C299D

P356

P1433

British Journal of Ophthalmology

P1476

Pharmacokinetics of ophthalmic corticosteroids.

@en

P2093

McGhee CN

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical evaluation of clobetasone butyrate eye drops in the treatment of anterior uveitis and its effects on intraocular pressure

Occlusion of the central retinal artery after retrobulbar corticosteroid injection

Review: systemic absorption of topically applied ocular drugs in humans

Use of orbital floor steroids in the management of patients with uniocular non-necrotising scleritis.

Device drug delivery to the eye. Collagen shields, iontophoresis, and pumps.

High doses of subconjunctival corticosteroid and antibody-forming cells in the eye and draining lymph nodes.

Drug interaction in the eye. Concurrent corticosteroid-antibiotic therapy for inflammatory keratitis.

Penetration of topically applied prednisolone sodium phosphate into human aqueous humour.

Prevention of experimental corneal allograft rejection in rabbits using cyclosporin-collagen shields.

Importance of the noncorneal absorption route in topical ophthalmic drug delivery.

P304

681-684

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.76.11.681

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

1992-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21678766

http://www.w3.org/2001/XMLSchema#string

P698

1477046

http://www.w3.org/2001/XMLSchema#string

P932

504375

http://www.w3.org/2001/XMLSchema#string